Patents
US 12760034 B2: Rifamycin analogs
- Granted
- 2026-10-13
- Filed
- 2022-01-19 application 18261932
- Type
- Utility · 28 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
Provided herein are compounds that are potent inhibitors of the Mycobacterium tuberculosis (MTB) RNA polymerase (RNAP), which exhibit significantly reduced activation of the human pregnane X receptor (hPXR), resulting in dramatically reduced C induction of hepatic cytochromes P450 2C9 and 3A4 (CYP2C9, CYP3A4), as well as a number of Phase II metabolism enzymes. Also provided herein are pharmaceutical compositions comprising the compounds, and methods of treating tuberculosis using the compounds.
Source: PTBLXML, file of 2026-10-13 (ipgb20261013.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2,342 patents | US company or organization | Ann Arbor, MI | THE REGENTS OF THE UNIVERSITY OF MICHIGAN CORP. State business registration FUZZY medium confidence: same name (legal endings aside) and state | PTBLXML, file of 2026-10-13 |
| THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 1,493 patents | US company or organization | Urbana, IL | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS Nonprofit EXACT high confidence: identical full name and state | PTBLXML, file of 2026-10-13 |
| THE PENN STATE RESEARCH FOUNDATION 710 patents | US company or organization | University Park, PA | The Penn State Research Foundation State business registration EXACT high confidence: identical full name and state PENN STATE RESEARCH FOUNDATION Nonprofit FUZZY medium confidence: same name (governing-board words and legal endings aside) and state | PTBLXML, file of 2026-10-13 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| George Garcia | Ann Arbor, MI | PTBLXML, file of 2026-10-13 | ||
| Hollis Showalter | Ann Arbor, MI | PTBLXML, file of 2026-10-13 | ||
| Walajapet Rajeswaran | Ann Arbor, MI | 3 | PTBLXML, file of 2026-10-13 | |
| Pil Lee | Ann Arbor, MI | PTBLXML, file of 2026-10-13 | ||
| Scott Franzblau | Urbana, IL | 2 | PTBLXML, file of 2026-10-13 | |
| Katsuhiko Murakami | University Park, PA | PTBLXML, file of 2026-10-13 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| C07D | Heterocyclic compounds | C07D498/18 | PTBLXML, file of 2026-10-13 |
| A61K | Preparations for medical, dental or toiletry purposes | A61K31/5386 | PTBLXML, file of 2026-10-13 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P31/06 | PTBLXML, file of 2026-10-13 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
No recorded assignments or security interests on file for this patent.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.